05-Oct-23 |
Shore Capital |
Not Rated |
37.50p |
- |
- |
Reiteration |
06-Mar-23 |
Barclays |
Underweight |
138.40p |
- |
70.00p |
Reiteration |
01-Apr-22 |
Liberum Capital |
Sell |
87.40p |
82.00p |
77.00p |
Reiteration |
24-Mar-22 |
RBC Capital Markets |
Sector perform |
85.75p |
- |
100.00p |
Reiteration |
12-Oct-20 |
Citigroup |
Neutral |
69.50p |
- |
- |
Reiteration |
10-Aug-20 |
Morgan Stanley |
Underweight |
103.60p |
100.00p |
100.00p |
Reiteration |
23-Oct-19 |
Jefferies |
Buy |
193.60p |
- |
297.00p |
Reiteration |
14-May-19 |
Berenberg Bank |
Hold |
508.00p |
1,200.00p |
600.00p |
Reiteration |
28-Feb-19 |
JP Morgan Cazenove |
Underweight |
889.50p |
1,300.00p |
790.00p |
Reiteration |
11-Jan-18 |
Investec Securities |
Sell |
3,650.00p |
3,575.00p |
3,585.00p |
DownGrade |
19-Sep-17 |
Macquarie |
Underperform |
3,488.00p |
- |
2,700.00p |
New Coverage |
26-Jul-17 |
Goldman Sachs |
Sell |
3,609.00p |
- |
2,580.00p |
Reiteration |
16:39 |
1,613 @ 34.80p |
16:35 |
70,124 @ 34.80p |
16:35 |
1 @ 34.80p |
16:35 |
4,640 @ 34.80p |
16:35 |
118 @ 34.80p |
CEO |
Daniel Frumkin |
Chair |
Robert Sharpe |
Top of Page
You are here:
research